BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8052210)

  • 1. Salk group testing killed-virus AIDS vaccine.
    Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052210
    [No Abstract]   [Full Text] [Related]  

  • 2. Tepid endorsement for HIV vaccine trial.
    Science; 1995 Feb; 267(5200):966. PubMed ID: 7863340
    [No Abstract]   [Full Text] [Related]  

  • 3. Infectious vaccines.
    Ross DW
    Arch Pathol Lab Med; 1998 Jan; 122(1):100-1. PubMed ID: 9448028
    [No Abstract]   [Full Text] [Related]  

  • 4. Salk's HIV immunogen: an immune-based therapy in human trials since 1988.
    Crit Path AIDS Proj; 1994-1995 Winter; (No 30):1, 20-3. PubMed ID: 11362152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [AIDS vaccine: who should be selected for the test?].
    Marcus U
    Fortschr Med; 1995 Nov; 113(32):16-7. PubMed ID: 8543269
    [No Abstract]   [Full Text] [Related]  

  • 6. Identifying barriers to participation in prophylactic HIV-1 vaccine trials.
    Peters BS
    Int J STD AIDS; 2006 Feb; 17(2):73. PubMed ID: 16464264
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral AIDS vaccine to be tested in the Republic of Uganda.
    Gottlieb S
    Bull World Health Organ; 2000; 78(7):945-6. PubMed ID: 10994272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merck's HIV vaccine flop brings vectors under closer scrutiny.
    Ledford H
    Nat Biotechnol; 2008 Jan; 26(1):3-4. PubMed ID: 18182999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nucleic acid vaccines for study in AIDS patients are approved. Vaccines of genetic molecules--humoral and cellular immune response].
    Hobom B
    Fortschr Med; 1995 Dec; 113(35-36):12. PubMed ID: 8582688
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive Phase 1 interim results for killed whole-virus HIV vaccine.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Jan; 9(1):7. PubMed ID: 23442582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady but slow progress toward AIDS vaccine.
    Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA advisory committees meet January 26 on Salk HIV-1 immunogen.
    AIDS Treat News; 1995 Jan; (No 214):1-2. PubMed ID: 11362184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of new vaccines for AIDS.
    Garrison L; Clements ML
    Compr Ther; 1989 Jul; 15(7):47-55. PubMed ID: 2670404
    [No Abstract]   [Full Text] [Related]  

  • 16. AIDS vaccine for mothers may protect newborns.
    Minn Med; 1993 Jun; 76(6):51. PubMed ID: 8316179
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAVI begins trials of AIDS vaccine.
    Expert Rev Vaccines; 2003 Dec; 2(6):731. PubMed ID: 15282843
    [No Abstract]   [Full Text] [Related]  

  • 19. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
    [No Abstract]   [Full Text] [Related]  

  • 20. Edible AIDS vaccine milestone.
    Expert Rev Vaccines; 2002 Jun; 1(1):6. PubMed ID: 12908506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.